These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32710995)

  • 1. Enhanced oral bioavailability and neuroprotective effect of fisetin through its SNEDDS against rotenone-induced Parkinson's disease rat model.
    Kumar R; Kumar R; Khurana N; Singh SK; Khurana S; Verma S; Sharma N; Kapoor B; Vyas M; Khursheed R; Awasthi A; Kaur J; Corrie L
    Food Chem Toxicol; 2020 Oct; 144():111590. PubMed ID: 32710995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved neuroprotective activity of Fisetin through SNEDDS in ameliorating the behavioral alterations produced in rotenone-induced Parkinson's model.
    Kumar R; Kumar R; Khurana N; Singh SK; Khurana S; Verma S; Sharma N; Vyas M; Dua K; Khursheed R; Awasthi A; Vishwas S
    Environ Sci Pollut Res Int; 2022 Jul; 29(33):50488-50499. PubMed ID: 35230633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the oral bioavailability of fisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery.
    Gunjal P; Vishwas S; Kumar R; Bashir B; Kumar B; Khurana N; Gulati M; Gupta G; Prasher P; Kumbhar P; Disouza J; Kuppusamy G; Mohammed Y; Dureja H; Dua K; Singh SK
    Drug Deliv Transl Res; 2024 Oct; 14(10):1-17. PubMed ID: 38789909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fisetin Improved Rotenone-Induced Behavioral Deficits, Oxidative Changes, and Mitochondrial Dysfunctions in Rat Model of Parkinson's Disease.
    Alikatte K; Palle S; Rajendra Kumar J; Pathakala N
    J Diet Suppl; 2021; 18(1):57-71. PubMed ID: 31992104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease.
    Khurana N; Gajbhiye A
    Neurotoxicology; 2013 Dec; 39():57-64. PubMed ID: 23994302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
    Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model.
    Sharma N; Khurana N; Muthuraman A; Utreja P
    Eur J Pharmacol; 2021 Jul; 903():174112. PubMed ID: 33901458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and α-synuclein expressions in rats.
    Ishola IO; Awogbindin IO; Olubodun-Obadun TG; Olajiga AE; Adeyemi OO
    Neurotoxicology; 2023 May; 96():37-52. PubMed ID: 36965781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
    Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
    Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bioavailability enhancement and hepatoprotective effects of thymoquinone by self-nanoemulsifying drug delivery system.
    Kalam MA; Raish M; Ahmed A; Alkharfy KM; Mohsin K; Alshamsan A; Al-Jenoobi FI; Al-Mohizea AM; Shakeel F
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():319-329. PubMed ID: 28482534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex.
    Shen J; Bi J; Tian H; Jin Y; Wang Y; Yang X; Yang Z; Kou J; Li F
    Int J Nanomedicine; 2016; 11():4919-4929. PubMed ID: 27713630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson's disease.
    Zhang Q; Chen S; Yu S; Qin J; Zhang J; Cheng Q; Ke K; Ding F
    Neuropharmacology; 2016 Sep; 108():238-51. PubMed ID: 27108097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
    Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Nanoemulsifying Drug Delivery System of Coenzyme (Q10) with Improved Dissolution, Bioavailability, and Protective Efficiency on Liver Fibrosis.
    Khattab A; Hassanin L; Zaki N
    AAPS PharmSciTech; 2017 Jul; 18(5):1657-1672. PubMed ID: 27677262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic evaluation of Solid self-nanoemulsifying delivery system (SSNEDDS) loaded with curcumin and duloxetine in attenuation of neuropathic pain in rats.
    Kumar B; Singh SK; Prakash T; Bhatia A; Gulati M; Garg V; Pandey NK; Singh S; Melkani I
    Neurol Sci; 2021 May; 42(5):1785-1797. PubMed ID: 32885394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System.
    Nekkanti V; Wang Z; Betageri GV
    AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of crystalline state and self-nanoemulsifying drug delivery system (SNEDDS) on oral bioavailability of the novel anti-HIV compound 6-benzyl-1-benzyloxymethyl-5-iodouracil in rats.
    Lu YY; Dai WB; Wang X; Wang XW; Liu JY; Li P; Lou YQ; Lu C; Zhang Q; Zhang GL
    Drug Dev Ind Pharm; 2018 Feb; 44(2):329-337. PubMed ID: 29113503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and optimisation of atorvastatin calcium loaded self-nanoemulsifying drug delivery system (SNEDDS) for enhancing oral bioavailability: in vitro and in vivo evaluation.
    Kassem AM; Ibrahim HM; Samy AM
    J Microencapsul; 2017 May; 34(3):319-333. PubMed ID: 28481663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS).
    Kang JH; Oh DH; Oh YK; Yong CS; Choi HG
    Eur J Pharm Biopharm; 2012 Feb; 80(2):289-97. PubMed ID: 22119666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.